Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Absci Corp
(NQ:
ABSI
)
4.098
+0.048 (+1.17%)
Streaming Delayed Price
Updated: 2:34 PM EDT, Sep 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Absci Corp
< Previous
1
2
3
4
5
6
7
Next >
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
December 11, 2023
If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
December 04, 2023
Collaboration Combines Absci’s AI Antibody Drug Creation Platform with AstraZeneca’s Expertise in Oncology Research and Development
From
Absci Corporation
Via
GlobeNewswire
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
AstraZeneca plc (NASDAQ: AZN) has reportedly finalized a partnership deal valued at up to $247 million with Absci Corporation (NASDAQ: ABSI), a U.S.-based firm specializing in artificial intelligence...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
November 15, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci's Return On Capital Employed Insights
April 03, 2023
Via
Benzinga
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
November 14, 2023
From
Absci Corporation
Via
GlobeNewswire
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
November 14, 2023
INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 14, 2023
We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
November 14, 2023
From
Almirall S.A.
Via
Business Wire
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
November 14, 2023
The collaboration expands Absci’s de novo AI drug creation portfolio into dermatology and accelerates discovery for broader chronic inflammatory diseases
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
October 26, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
September 21, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci to Host R&D Day on October 4, 2023
September 06, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
August 28, 2023
From
Absci Corporation
Via
GlobeNewswire
The 3 Most Undervalued Penny Stocks to Buy Now: August 2023
August 14, 2023
These undervalued penny stocks each provide big upside potential, while trading with relatively high margins of safety.
Via
InvestorPlace
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
August 14, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
August 14, 2023
Addition of veteran biotech leader to further support Absci’s next stage of growth
From
Absci Corporation
Via
GlobeNewswire
Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development
August 10, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023
August 01, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
June 15, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips
June 06, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
May 15, 2023
From
Absci Corporation
Via
GlobeNewswire
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 22, 2023
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.
Via
Benzinga
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
May 11, 2023
Absci will apply its generative AI platform to The Kennedy Institute’s immunology biorepository to speed the discovery and development of multiple therapies
From
Absci Corporation
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Via
Benzinga
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 06, 2023
From
Absci Corporation
Via
GlobeNewswire
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
April 04, 2023
Absci’s generative AI platform will use M2GEN’s industry-leading clinicogenomic database with the aim of creating better cancer treatments faster
From
Absci Corporation
Via
GlobeNewswire
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
March 30, 2023
From
Absci Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.